1. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma
   Michela Bottani et al, 2019, Journal of Clinical Medicine CrossRef
2. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma
   Zhenzhen Liang et al, 2016, Digestive and Liver Disease CrossRef
3. Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors
   Ivana Peran et al, 2022, Cancers CrossRef
4. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
   Aiko Sueta et al, 2017, Oncotarget CrossRef
5. A Novel High-Dimensional Kernel Joint Non-Negative Matrix Factorization With Multimodal Information for Lung Cancer Study
   Yuhu Shi et al, 2024, IEEE Journal of Biomedical and Health Informatics CrossRef
6. Circulating or tissue microRNAs and extracellular vesicles as potential lung cancer biomarkers: a systematic review
   Yan Song et al, 2018, The International Journal of Biological Markers CrossRef
7. Circular RNAs are abundantly expressed and upregulated during repair of the damaged endometrium by Wharton’s jelly-derived mesenchymal stem cells
   Baolan Sun et al, 2018, Stem Cell Research & Therapy CrossRef
8. Molecular Biomarkers for Celiac Disease: Past, Present and Future
   Aarón D. Ramírez-Sánchez et al, 2020, International Journal of Molecular Sciences CrossRef
9. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non‐small cell Lung Cancer: A retrospective study
   Xin Wang et al, 2017, Thoracic Cancer CrossRef
10. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review
    Reilly J. Clark et al, 2018, Oncotarget CrossRef
11. MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis
    Min Jiang et al, 2018, Oncotarget CrossRef
12. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
    Anetta Sulewska et al, 2023, Cells CrossRef
13. MicroRNA-574-5p promotes metastasis of non-small cell lung cancer by targeting PTPRU
    Rui Zhou et al, 2016, Scientific Reports CrossRef
14. Diagnostic and prognostic value of microRNA-486 in patients with lung cancer: A systematic review and meta-analysis
    Xiaoyu Shen et al, 2022, The International Journal of Biological Markers CrossRef
15. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo
    Liwei Ni et al, 2021, European Journal of Pharmacology CrossRef
16. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study
    Weronika Zofia Świtlik et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef